According to a report by CBS, the Food and Drug Administration (FDA) of the United States is expected to finalize regulations prohibiting the sale of menthol cigarettes and flavored cigars in the "coming months.
In April 2022, the FDA announced plans to ban the sale of these flavored tobacco products and set a deadline of August 2023 to establish specific regulations. However, the agency failed to release any relevant announcement last month.
Despite the fact that smoking rates in the United States have reached an all-time low, according to the data from the Centers for Disease Control and Prevention, the proportion of individuals smoking menthol cigarettes is on the rise.
Tobacco companies argue that there are better ways to reduce the health impact of smoking rather than banning menthol flavor in cigarettes. Vice President of Corporate Communication and Media Relations at Reynolds American Inc., Louis Pinto, stated in an email to CBS News, "Evidence from other markets, including Canada and the European Union, suggests that similar bans have had little to no impact on overall cigarette consumption.
Experts say that even if the FDA enforces a nationwide ban, it could take several years for it to become fully effective due to the likelihood of tobacco companies challenging the measure in court.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
